- Home
- CLDX vs EH Comparison
CLDX vs EH Comparison
Compare CLDX & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- EH
- Stock Information
- Founded
- CLDX N/A
- EH 2014
- Country
- CLDX United States
- EH China
- Employees
- CLDX N/A
- EH N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EH Military/Government/Technical
- Sector
- CLDX Health Care
- EH Industrials
- Exchange
- CLDX Nasdaq
- EH Nasdaq
- Market Cap
- CLDX 1.3B
- EH 1.2B
- IPO Year
- CLDX 2008
- EH 2019
- Fundamental
- Price
- CLDX $23.36
- EH $17.62
- Analyst Decision
- CLDX Buy
- EH Strong Buy
- Analyst Count
- CLDX 9
- EH 3
- Target Price
- CLDX $50.00
- EH $24.80
- AVG Volume (30 Days)
- CLDX 1.1M
- EH 1.3M
- Earning Date
- CLDX 08-07-2025
- EH 08-21-2025
- Dividend Yield
- CLDX N/A
- EH N/A
- EPS Growth
- CLDX N/A
- EH N/A
- EPS
- CLDX N/A
- EH N/A
- Revenue
- CLDX $7,559,000.00
- EH $57,950,389.00
- Revenue This Year
- CLDX N/A
- EH $102.39
- Revenue Next Year
- CLDX N/A
- EH $59.66
- P/E Ratio
- CLDX N/A
- EH N/A
- Revenue Growth
- CLDX 24.49
- EH 167.93
- 52 Week Low
- CLDX $14.40
- EH $10.40
- 52 Week High
- CLDX $47.00
- EH $29.76
- Technical
- Relative Strength Index (RSI)
- CLDX 64.61
- EH 58.01
- Support Level
- CLDX $20.76
- EH $16.59
- Resistance Level
- CLDX $23.55
- EH $17.29
- Average True Range (ATR)
- CLDX 1.22
- EH 0.72
- MACD
- CLDX 0.20
- EH 0.11
- Stochastic Oscillator
- CLDX 95.29
- EH 85.87
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.